IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Aurobindo Pharma reports rise in API sales

12:51 PM MST | February 12, 2014 | Deepti Ramesh

The active pharmaceutical ingredient (API) business of Aurobindo Pharma (Hyderabad, India) reports a 12.7% rise in sales in the company’s fiscal third quarter, ended 31 December 2013, compared with the year-ago quarter, to 7.44 billion Indian rupees ($120 million). Earnings figures for the API business have not been disclosed. Aurobindo is one of the global leaders in APIs. Cephalosporin accounted for Rs2.17 billion of Aurobindo’s total API sales of in the fiscal third quarter, semisynthetic penicillin accounted for Rs2.58 billion, and nonbetalactam...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa